165 related articles for article (PubMed ID: 15243035)
21. The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?
Pan J; Yao P; Zhang H; Sun X; He H; Xie S
Int J Infect Dis; 2014 Dec; 29():62-4. PubMed ID: 25449237
[TBL] [Abstract][Full Text] [Related]
22. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
[TBL] [Abstract][Full Text] [Related]
23. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
Kahler CM; Martin LE; Shih GC; Rahman MM; Carlson RW; Stephens DS
Infect Immun; 1998 Dec; 66(12):5939-47. PubMed ID: 9826376
[TBL] [Abstract][Full Text] [Related]
24. [A method for determination of Neisseria meningitidis serogroup A, B, C and W by real-time PCR].
Mironov KO; Platonov AE; Dribnokhodova OP; Kuseva VI; Shipulin GA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):35-42. PubMed ID: 25816511
[TBL] [Abstract][Full Text] [Related]
25. Biofilm formation by Neisseria meningitidis.
Yi K; Rasmussen AW; Gudlavalleti SK; Stephens DS; Stojiljkovic I
Infect Immun; 2004 Oct; 72(10):6132-8. PubMed ID: 15385518
[TBL] [Abstract][Full Text] [Related]
26. Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.
Hollanda LM; Cury GC; Pereira RF; Ferreira GA; Sousa A; Sousa EM; Lancellotti M
J Nanobiotechnology; 2011 Jul; 9():28. PubMed ID: 21787408
[TBL] [Abstract][Full Text] [Related]
27. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.
Hammerschmidt S; Müller A; Sillmann H; Mühlenhoff M; Borrow R; Fox A; van Putten J; Zollinger WD; Gerardy-Schahn R; Frosch M
Mol Microbiol; 1996 Jun; 20(6):1211-20. PubMed ID: 8809773
[TBL] [Abstract][Full Text] [Related]
28. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
Vogel U; Weinberger A; Frank R; Müller A; Köhl J; Atkinson JP; Frosch M
Infect Immun; 1997 Oct; 65(10):4022-9. PubMed ID: 9317002
[TBL] [Abstract][Full Text] [Related]
29. Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes.
Hotopp JCD; Grifantini R; Kumar N; Tzeng YL; Fouts D; Frigimelica E; Draghi M; Giuliani MM; Rappuoli R; Stephens DS; Grandi G; Tettelin H
Microbiology (Reading); 2006 Dec; 152(Pt 12):3733-3749. PubMed ID: 17159225
[TBL] [Abstract][Full Text] [Related]
30. [Chronic meningococcemia caused by Neisseria meningitidis of serogroup C].
Suriñach JM; Alegre J; García Patos V; Planes A; Fernández de Sevilla T
Enferm Infecc Microbiol Clin; 1995; 13(7):439-40. PubMed ID: 8519824
[No Abstract] [Full Text] [Related]
31. Capsule switching of Neisseria meningitidis.
Swartley JS; Marfin AA; Edupuganti S; Liu LJ; Cieslak P; Perkins B; Wenger JD; Stephens DS
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):271-6. PubMed ID: 8990198
[TBL] [Abstract][Full Text] [Related]
32. Analysis of transcriptional control mechanisms of capsule expression in Neisseria meningitidis.
Von Loewenich FD; Wintermeyer E; Dümig M; Frosch M
Int J Med Microbiol; 2001 Nov; 291(5):361-9. PubMed ID: 11727820
[TBL] [Abstract][Full Text] [Related]
33. [Genetic characteristics of Neisseria meningitidis strains obtained from healthy carriers during meningococcal infection outbreaks].
Mironov KO; Tagachenkova TA; Koroleva IS; Platonov AE; Shipulin GA
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):22-9. PubMed ID: 21598611
[TBL] [Abstract][Full Text] [Related]
34. Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis.
Bos MP; Tommassen J
Infect Immun; 2005 Sep; 73(9):6194-7. PubMed ID: 16113348
[TBL] [Abstract][Full Text] [Related]
35. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
36. [Spontaneous bacterial peritonitis and bacteraemia caused by meningococci serogroup W clonal complex 11].
Iversen MS; Hoffmann S; Lind K; Dungu A; Johannesen TB; Holzknecht BJ
Ugeskr Laeger; 2018 Apr; 180(16):. PubMed ID: 29690994
[TBL] [Abstract][Full Text] [Related]
37. Whole-Genome Sequencing for Characterization of Capsule Locus and Prediction of Serogroup of Invasive Meningococcal Isolates.
Marjuki H; Topaz N; Rodriguez-Rivera LD; Ramos E; Potts CC; Chen A; Retchless AC; Doho GH; Wang X
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567750
[TBL] [Abstract][Full Text] [Related]
38. Neisseria meningitidis: an overview of the carriage state.
Yazdankhah SP; Caugant DA
J Med Microbiol; 2004 Sep; 53(Pt 9):821-832. PubMed ID: 15314188
[TBL] [Abstract][Full Text] [Related]
39. The (alpha2-->8)-linked polysialic acid capsule of group B Neisseria meningitidis modifies multiple steps during interaction with human macrophages.
Read RC; Zimmerli S; Broaddus C; Sanan DA; Stephens DS; Ernst JD
Infect Immun; 1996 Aug; 64(8):3210-7. PubMed ID: 8757855
[TBL] [Abstract][Full Text] [Related]
40. Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis.
Hilse R; Stoevesandt J; Caugant DA; Claus H; Frosch M; Vogel U
Epidemiol Infect; 2000 Apr; 124(2):337-40. PubMed ID: 10813160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
